Commitments And Contingencies (Narrative) (Details) claim in Thousands, $ in Thousands	1 Months Ended			3 Months Ended	6 Months Ended	12 Months Ended	13 Months Ended	19 Months Ended
	Oct. 31, 2015 motion	Aug. 31, 2015	Sep. 30, 2013 company	Jun. 30, 2017 USD ($) claim	Jun. 30, 2017 USD ($) case	Dec. 31, 2012 patent	Oct. 30, 2013	Jun. 30, 2017 USD ($) complaint	Jul. 31, 2017 case	Dec. 31, 2016 USD ($)
Loss Contingencies [Line Items]
Reserve for loss contingencies				$ 1,335,600	$ 1,335,600			$ 1,335,600
Current portion of legal settlement accrual				909,831	909,831			909,831		$ 1,015,932
Opana
Gain Contingencies [Line Items]
Lawsuit filing period							45 days
Stay of approval period, Hatch-Waxman Act							30 months
Vaginal Mesh Cases
Loss Contingencies [Line Items]
Product liability accrual increase				$ 775,500
Number of expected claims to be covered | claim				22
Current portion of legal settlement accrual				$ 868,900	868,900			868,900
Payments to plaintiffs and qualified settlement funds					2,800,000
Settlement funds				359,077	359,077			$ 359,077		$ 275,987
Testosterone Cases | Subsequent Event
Loss Contingencies [Line Items]
Pending claims, number | case									1,285
Unapproved Drug Litigation
Loss Contingencies [Line Items]
Number of additional pharmaceutical companies named in petitions (over 50) | company			50
Pricing Matters Cases
Loss Contingencies [Line Items]
Number of complaints | complaint								2
Judicial Ruling | Opana
Gain Contingencies [Line Items]
Number of patents found infringed upon | patent						2
Period for generic product to be withdrawn	60 days	60 days
Number of post-trial motions | motion	2
AMS | Vaginal Mesh Cases
Loss Contingencies [Line Items]
Product liability accrual, period expense				$ 1,294,600	$ 1,294,600			$ 1,294,600
Loss contingency, claims settled, number | case					71,000